ReviewMaterials today. Bio2025
Multiscale interface engineering in biohybrid composites for biomedical applications.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Applications of Nanofabrication Technologies in the Preparation of Biomimetic Structures.Biomimetics (Basel, Switzerland) · 2026Review
- Hydrogels: current biomedical applications and future directions.Molecular biomedicine · 2026Review
- Bioinspired and living multiscale composites for regenerative medicine in the treatment of surgical site infections.Journal of nanobiotechnology · 2026Review
- Multiscale Interface Engineering for Orthopedic and Dental Implants: A Review.Journal of functional biomaterials · 2026Review
- Data-driven multiscale design of composite biomaterials: Integrating experiments, imaging, and computational modeling for biomedical engineering.Materials today. Bio · 2026Review
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiscale composites with engineered interfaces have emerged as a cornerstone in the development of next-generation biomedical materials. This review provides a comprehensive and structured overview of interface design strategies spanning nano-to macro-scales, emphasizing their role in modulating mechanical performance, biological signaling, and adaptive functionality. We categorize key approaches into three synergistic domains: hierarchical structuring for mechanical and cellular control, stimuli-responsive interfaces for dynamic biomedical functions, and bioinspired or living systems that mimic and integrate with biological environments. Advanced fabrication techniques-including additive manufacturing, surface nanofunctionalization, and layer-by-layer assembly-are reviewed alongside multiscale characterization tools for structural and interfacial analysis. We further link these interface strategies to a range of biomedical applications, such as osteochondral scaffolds, vascularized implants, antibacterial coatings, smart drug delivery carriers, and neural-integrated electronics. Biological interactions, including protein adsorption, mechanotransduction, and immune modulation, are explored to elucidate how engineered interfaces influence cellular fate and integration. Finally, we outline key challenges-such as manufacturing scalability, long-term biocompatibility, and regulatory approval-and propose forward-looking solutions enabled by AI-driven materials design and organ-on-chip validation. This review serves as a conceptual and technical roadmap for researchers developing multifunctional biomaterials through the lens of multiscale interface engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.